Product News
Filter News
Found 176,161 articles
-
Imprimis to Offer Compounded Cyclosporine Alternative to Restasis
10/19/2017
Imprimis today announced it is making compounded Cyclosporine-based formulations available for physicians to consider prescribing as customizable and potentially lower-cost alternatives to Restasis.
-
Quad Technologies Patents Novel T-Cell Activation Reagent For Car-T Cell Manufacturing
10/19/2017
Quad Technologies, a leader in cell and gene therapy bioprocessing reagents, announced today the U.S. Patent and Trademark Office has awarded the company a new U.S. Patent, No. 9,790,467, titled "Methods and Compositions for activation or expansion of T lymphocytes".
-
Devana Solutions Release: Site Selection Made More Effective For Sponsors, CROs Through Disruptive Devana Solutions Technology
10/19/2017
Site selection for clinical trials is one of the biggest headaches for pharmaceutical Sponsors and CROs, with almost half of sites enrolling zero or one patient.
-
Adobe Sign Certified Compliant with SAFE-BioPharma Standard
10/19/2017
Adobe Sign, the leading e-signature solution that allows anyone to sign and send documents, is now certified compliant with the global SAFE-BioPharma digital signature standard.
-
Pear Therapeutics Receives Expedited Access Pathway Designation from FDA for reSET-O™ Prescription Digital Therapeutic to Treat Opioid Use Disorder
10/19/2017
Pear Therapeutics, the leader in prescription digital therapeutics, today announced that it has received an Expedited Access Pathway (EAP) designation from FDA for its reSET-O Prescription Digital Therapeutic, the first of its kind designed for treating Opioid Use Disorder (OUD).
-
Benson Hill Biosystems Launches the First Fully Enabling Genome Editing System for Crop Improvement
10/19/2017
Benson Hill Biosystems today announced at the Future Food-Tech Conference the commercial launch of Edit, powered by CropOS, the first complete genome editing system made accessible to partners for the development of improved crops.
-
City Of Hope, Leading Cancer Research And Treatment Center, To Provide First-Ever FDA-Approved CAR-T Cell Therapy For Adult Patients With Certain Types Of Large B-Cell Lymphoma
10/19/2017
City of Hope will be one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. Food and Drug Administration (FDA) announced today is the first approved CAR-T cell therapy.
-
TraceLink Hits Industry Milestone with 100 Contract Manufacturing Organizations Serialization-Ready on the Life Sciences Cloud Network
10/19/2017
TraceLink today announced that more than 100 CMOs are fully configured on the TraceLink Life Sciences Cloud and ready to exchange serialization data.
-
IDBS Takes Bioanalysis Informatics To The Cloud
10/19/2017
Today IDBS has announced the release of its next-generation bioanalytical informatics solution.
-
NuVasive Launches New 3D-Printed Porous Titanium Implant In Expanding Advanced Materials Science Portfolio
10/19/2017
NuVasive today announced the launch of Modulus XLIF titanium implants.
-
Entatio Announced the Release of Entatio for Pharma, a Media Application Designed to Connect Medical Researchers and Physicians
10/19/2017
Entatio today announced the release of Entatio for Pharma, a cloud application built specifically for pharmaceutical and medical device companies to aid in the delivery of highly regulated medical content to physicians through medical conferences and events.
-
Life Spine Announces Alpha Release Of The SENTRY ALIF Plating System
10/19/2017
Life Spine, a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spinal disorders today announced the Alpha launch of the SENTRY ALIF Plating System.
-
Thermo Fisher Scientific and Wellcome Trust Sanger Institute Announce the Axiom Africa Array for Medical and Population Genomics
10/19/2017
Thermo Fisher Scientific today announced the commercial launch of the Applied Biosystems Axiom Africa Array for medical and population genomics to accelerate and support initiatives in global health and population research.
-
PolarityTE Lead Product, SkinTE, is Approved for Use by Multiple Medical Institutions
10/19/2017
Clinical application is expected in the fourth quarter of 2017, and data is planned to be released through multiple channels in the first half of 2018.
-
European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy System
10/19/2017
Accuray announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy System by University Hospital of Tours (CHU).
-
CytoSorbents Release: CytoSorb Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival
10/19/2017
CytoSorbents highlights the largest endocarditis valve replacement study using CytoSorb published to date entitled, "Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series".
-
Medigus Receives First Purchase Order From Izasa Hospital in Spain for Its MUSE System
10/19/2017
Medigus announced that Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector, has provided an initial purchase order (PO) for the Medigus Ultrasonic Surgical Endostapler, or MUSE system.
-
Tempus Unveils Tempus xT, 595 Gene Panel Aimed at Empowering Data-Driven Cancer Care
10/19/2017
Tempus xT analyzes 595 genes relevant to the diagnosis, prognosis and therapeutic targeting of cancer.
-
BioSig Technologies Advances Towards Commercialization Into the Global Electrophysiology Market Estimated to Reach $8.2B by 2022
10/19/2017
Recent hire marks entry to next phase of corporate development.
-
AirXpanders' AeroForm Tissue Expander System Named Best of What's New by Popular Science
10/19/2017
AirXpanders today that its AeroForm System earned a Best of What's New award in the health category by Popular Science, the world's largest science and technology magazine.